Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Inventory (2016 - 2026)

Usana Health Sciences has reported Inventory over the past 16 years, most recently at $96.4 million for Q2 2026.

  • Quarterly Inventory rose 31.0% to $96.4 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $96.4 million through Apr 2026, up 31.0% year-over-year, with the annual reading at $102.6 million for FY2026, 47.14% up from the prior year.
  • Inventory was $96.4 million for Q2 2026 at Usana Health Sciences, down from $102.6 million in the prior quarter.
  • Over five years, Inventory peaked at $102.6 million in Q1 2026 and troughed at $60.1 million in Q3 2023.
  • The 5-year median for Inventory is $68.5 million (2022), against an average of $75.9 million.
  • Year-over-year, Inventory tumbled 33.91% in 2023 and then soared 47.14% in 2026.
  • A 5-year view of Inventory shows it stood at $67.1 million in 2022, then dropped by 8.4% to $61.5 million in 2023, then rose by 13.48% to $69.7 million in 2024, then surged by 30.18% to $90.8 million in 2025, then rose by 6.14% to $96.4 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Inventory are $96.4 million (Q2 2026), $102.6 million (Q1 2026), and $90.8 million (Q3 2025).